IRIS

Chlordane (Technical)

CASRN 12789-03-6 | DTXSID5023954

  • IRIS Summary (PDF) (46 pp, 262 K)
  • Status: EPA announced in a 2004 Federal Register Notice that chemicals used as pesticides would not be re-assessed by the IRIS Program. This entry in the IRIS database is preserved at the request of EPA program and regional offices. Additional toxicological information may be found under "Other EPA Information."

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (46 pp, 262 K) Last Updated: 02/07/1998

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Hepatic 5 x 10-4 Hepatic necrosis NOAEL : 1.5 x 10-1
mg/kg-day
300 Medium

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (46 pp, 262 K) Last Updated: 02/07/1998

System RfC (mg/m3) Basis PoD Composite UF Confidence
Hepatic 7 x 10-4 Hepatic effects NOAEL (HEC): 6.5 x 10-1
mg/m3
1000 Low

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (46 pp, 262 K) Last Updated: 02/07/1998

WOE Characterization Framework for WOE Characterization
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1986)
Known/likely human carcinogen Proposed Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1996)
Basis:
  • Under the 1996 Proposed Guidelines, chlordane would be characterized as a likely carcinogen by all routes of exposure.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (46 pp, 262 K)

Oral Slope Factor: 3.5 x 10 -1 per mg/kg-day
Drinking Water Unit Risk: 1 x 10 -5 per µg/L
Extrapolation Method: Linearized multistage procedure, extra risk
Tumor site(s): Hepatic
Tumor type(s): Hepatocellular carcinoma (IRDC, 1973; NCI, 1977; Khasawinah and Grutsch, 1989b)



Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (46 pp, 262 K)

Inhalation Unit Risk: 1 x 10 -4 per µg/m3
Extrapolation Method: Linearized multistage procedure, extra risk
Tumor site(s): Hepatic
Tumor type(s): Hepatocellular carcinoma (IRDC, 1973; NCI, 1977; Khasawinah and Grutsch, 1989b)


Additional EPA toxicity information may be available by visiting the following sites:

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.